CSTE.NASDAQCaesarstone LTD

20-F: Caesarstone Reports Steep Losses Amid Plant Closures, Legal Battles

Sentiment:

Annual Report


Caesarstone Ltd. reported a significant net loss of $137.5 million in 2025, alongside declining revenues and escalating legal expenses from silicosis claims, as it navigates major operational restructuring and market challenges.

Capital raiseThe company may need to raise funds to finance existing and future capital needs, including ongoing working capital requirements or funding bodily injury claims or settlements.Raising funds through the sale of equity securities may dilute the value of outstanding ordinary shares.Any debt financing would increase the level of indebtedness, negatively affect liquidity, restrict operations, and may prove expensive due to increasing interest rates.There is no assurance that additional funds can be raised on terms favorable to the company or at all.
Worse than expectedNet loss attributable to controlling shareholders significantly increased to $137.5 million in 2025 from $42.8 million in 2024.Adjusted EBITDA was a loss of $32.6 million in 2025, worsening from a $11.5 million loss in 2024.Revenue decreased by 10.4% in 2025, following a 21.5% decrease in 2024, indicating continued decline.Gross margin decreased to 18.4% in 2025 from 21.8% in 2024.Legal settlements and loss contingencies expenses increased substantially to $25.6 million in 2025 from $7.2 million in 2024.Impairment charges of $45.7 million were recorded in 2025, primarily due to plant closures.Cash used in operating activities was $38.0 million in 2025, a negative shift from cash provided in previous years.

Summary

  • Caesarstone reported a net loss attributable to controlling shareholders of $137.5 million in 2025, a substantial increase from a $42.8 million loss in 2024.
  • Revenue decreased by 10.4% to $397.2 million in 2025, following a 21.5% decline in 2024 (on a constant currency basis).
  • Adjusted EBITDA was a loss of $32.6 million in 2025, worsening from a $11.5 million loss in 2024.
  • Gross margin declined to 18.4% in 2025 from 21.8% in 2024.
  • The company incurred $45.7 million in impairment charges in 2025, primarily related to the closure of its Bar Lev plant in Israel and the held-for-sale Richmond Hill facility in the U.S.
  • Legal settlements and loss contingencies expenses surged to $25.6 million in 2025, up from $7.2 million in 2024, mainly due to silicosis claims.
  • Cash used in operating activities amounted to $38.0 million in 2025, a reversal from cash provided in prior years.
  • As of December 31, 2025, the company faced 618 pending bodily injury claims globally related to silica exposure (40 in Israel, 151 in Australia, 427 in the U.S.), with a provision of $47.3 million recorded for probable and estimable losses.
  • Insurance receivables for silicosis-related claims decreased to $11.0 million in 2025 from $32.1 million in 2024, and recovery from U.S. insurance carriers is not considered probable.
  • The Australian ban on engineered stone containing crystalline silica, effective July 1, 2024, contributed to a 10.5% revenue decrease in Australia in 2025.
  • The company completed the acquisition of the remaining minority interest in Lioli Ceramica Pvt. Ltd., an India-based porcelain slab producer, for approximately $1.9 million, achieving 100% ownership.
  • Capital expenditures for 2025 were $9.0 million, down from $10.4 million in 2024 and $11.2 million in 2023.
  • The company's stock price fell below $1.00 in November 2025, raising concerns about Nasdaq listing compliance.
  • Kibbutz Sdot-Yam and Tene beneficially owned 40.6% of the company's outstanding ordinary shares as of February 27, 2026.

Sentiment

Score: 2

Explanation: StockSavvy.ai views this as a highly concerning report, reflecting significant financial deterioration, escalating legal liabilities, and operational challenges in a competitive and evolving regulatory landscape.

Positives

  • Completed the acquisition of the remaining minority equity interests in Lioli Ceramica Pvt. Ltd. for approximately $1.9 million, resulting in 100% ownership of the porcelain slab manufacturer.
  • R&D efforts are focused on developing innovative crystalline silica-free (CSF) products and expanding porcelain product offerings, aligning with evolving market demands and regulatory changes.
  • Implemented cost savings measures in selling and marketing activities, contributing to a $6.7 million decrease in these expenses in 2025.
  • Experienced an 11.0% increase in revenues in Israel in 2025, attributed to increased market activity following the end of the war on terror.
  • Subleased a majority of available land at the Sdot-Yam facility to third parties, generating approximately $3.4 million in 2025 and $1.1 million in 2024.
  • Digital transformation projects are underway to enhance consumer engagement and customer experience, with the company's website recognized by Forbes Advisor as a Top WordPress Website in November 2024.

Negatives

  • Reported a significant net loss attributable to controlling shareholders of $137.5 million in 2025, compared to a $42.8 million loss in 2024.
  • Adjusted EBITDA was a loss of $32.6 million in 2025, worsening from a $11.5 million loss in 2024, indicating deteriorating operational profitability.
  • Revenue decreased by 10.4% to $397.2 million in 2025, continuing a downward trend from a 21.5% decrease in 2024, driven by competitive pressures and macroeconomic headwinds.
  • Gross margin declined to 18.4% in 2025 from 21.8% in 2024, impacted by lower sales, reduced average selling prices, higher manufacturing costs per unit due to lower capacity utilization, and increased logistics costs and tariffs.
  • Incurred substantial impairment charges of $45.7 million in 2025, primarily due to the closure of the Bar Lev plant and the held-for-sale Richmond Hill facility.
  • Legal settlements and loss contingencies expenses increased significantly to $25.6 million in 2025 from $7.2 million in 2024, mainly attributed to silicosis claims in the U.S. and Australia.
  • Cash used in operating activities was $38.0 million in 2025, a negative shift from cash provided in the two prior years, indicating a strain on operational liquidity.
  • The Australian ban on engineered stone containing crystalline silica, effective July 1, 2024, negatively impacted sales in Australia by 10.5% in 2025.
  • Insurance recovery for U.S. silica-related claims is not probable, and the company is engaged in legal disputes with insurance carriers regarding coverage limits.
  • The company's share price dropped to an all-time low of $0.86 per share in November 2025, raising concerns about compliance with Nasdaq's minimum bid price requirement.

Risks

  • Adverse outcomes and potential losses from bodily injury claims, particularly silicosis, may have a material adverse effect on business, operating results, financial condition, and cash flows.
  • Inability to obtain insurance coverage for future silicosis claims, disputes over existing policy coverage, and potential insufficiency of coverage if claims are not accepted by courts and juries.
  • Global trade is affected by governmental involvement, including antidumping and countervailing duties, which may cause unforeseeable market changes and adversely impact financial results.
  • Changes in laws and regulations relating to hazards associated with engineered stone surfaces or crystalline silica (e.g., Australian ban, California petition for ban, OSHA enforcement) may adversely and materially affect the business.
  • Reliance on a network of third-party Production Business Partners (PBPs) introduces concentration risks, potential for production delays, IP leakage, quality control issues, and supply chain challenges.
  • Economic downturns, particularly in home renovation and construction, may materially and adversely impact end-consumer demand for products.
  • Adverse global conditions, including macroeconomic slowdowns, recessions, and geopolitical instability (e.g., Red Sea disruptions, Russian-Ukraine conflict), may continue to negatively impact financial results.
  • Intense competitive pressures from other surface materials and low-cost manufacturers could materially and adversely affect results of operations and financial condition.
  • Cannot guarantee the success of new products and materials, potentially leading to higher-than-expected expenses, lower sales, and loss of market share.
  • Disruptions to or failure to upgrade and adjust information technology systems globally, including cybersecurity threats, may materially impair operations.
  • Fluctuations in currency exchange rates may materially and adversely affect results of operations, and hedging strategies may not be adequate.
  • Inability to offset or pass on increases in costs or adverse changes in global sourcing, manufacturing, and supply conditions.
  • Failure to effectively manage required changes in the supply chain could hinder market service or lead to additional inefficiencies.
  • A sizable proportion of North American sales is attributable to a limited number of large retailers; any deterioration of relationships or their business performance could adversely impact results.
  • Significant geographic concentration of sales (82% from US, Australia, Canada, Israel); disruption in any key market could materially and adversely impact results.
  • Failure to expand sales in certain markets (e.g., United States) and segments (e.g., services) would have a material adverse effect on future growth and prospects.
  • Distributors' actions may have a materially adverse effect on business and results of operations, including potential litigation from terminations.
  • Business is subject to disruptions and quarterly fluctuations in revenues and net income (loss) due to seasonal factors, weather-related conditions, natural disasters, and building construction cycles.
  • May need to raise funds to finance current and future capital needs, which may dilute the value of outstanding ordinary shares, increase financial expenses, or limit business activities.
  • Ability to fully integrate acquisitions, joint ventures, and investments could be more difficult, costly, and time-consuming than expected, disrupting business and adversely affecting financial results.
  • Compliance with continuously evolving privacy laws and regulations (e.g., CCPA, CPRA, GDPR, Israeli PPL) may result in significant liability, negative publicity, and/or erosion of trust.
  • Exposure to greater-than-anticipated tax liabilities, including challenges to transfer pricing arrangements and potential loss or reduction of tax benefits in Israel.
  • Environmental, health, and safety regulations, industry standards, and other similar matters may be costly, difficult, or impossible to comply with, negatively impacting financial condition and results of operations.
  • Litigation, disputes, or other proceedings (beyond product liability claims) could result in unexpected expenses and divert management resources.
  • Failure to meet ESG expectations or standards or to effectively pursue ESG goals could adversely affect business, results of operations, financial condition, or stock price.
  • Operating results may suffer due to failure to manage international operations effectively or due to regulatory changes in foreign jurisdictions.
  • Certain U.S. holders of ordinary shares may suffer adverse tax consequences if the company or its non-U.S. subsidiaries are characterized as a Controlled Foreign Corporation (CFC) or Passive Foreign Investment Company (PFIC).
  • Directors and employees who are members of Kibbutz Sdot-Yam and Tene may have conflicts of interest with respect to matters involving the company.
  • Regulators and other third parties may question whether agreements with Kibbutz Sdot-Yam are no less favorable than if negotiated with unaffiliated third parties.
  • Under Israeli law, the board, audit committee, and sometimes shareholders may be required to reapprove certain agreements with controlling shareholders every three years, and improper approval may expose the company to liability.
  • Dependence on Kibbutz Sdot-Yam with respect to leasing buildings and areas of the manufacturing facility in Israel.
  • The price of ordinary shares may be volatile and impacted by Nasdaq listing requirements, including the minimum bid price.
  • Goodwill or other intangible assets or long-lived assets may become subject to impairment (as experienced in 2023, 2024, and 2025).
  • Share price is impacted by reports from research analysts, publicly announced financial guidance, investor perceptions, and the ability to meet other expectations about the business.
  • The substantial share ownership position of Kibbutz Sdot-Yam and Tene will limit other shareholders' ability to influence corporate matters.
  • Future sales of ordinary shares could negatively affect the market price.
  • Articles of association designate U.S. federal district courts as the sole and exclusive forum for Securities Act claims and Tel Aviv courts for Israeli Securities Law claims, potentially limiting shareholders' ability to bring claims.
  • As a foreign private issuer, the company may follow certain home country corporate governance practices instead of Nasdaq requirements and is exempt from certain U.S. proxy rules and Regulation FD.
  • Conditions in Israel and regional instability may adversely affect operations.
  • Operations may be affected by labor unrest in Israel.
  • Tax benefits available in Israel require meeting various conditions and may be terminated or reduced in the future.
  • It may be difficult to enforce a U.S. judgment against the company, its officers, and directors in Israel or the United States, or to assert U.S. securities laws claims in Israel.
  • Your rights and responsibilities as a shareholder will be governed by Israeli law, which may differ from those of shareholders of United States corporations.
  • Provisions of Israeli law and the articles of association may delay, prevent, or make undesirable a merger transaction or an acquisition of all or a significant portion of ordinary shares.
  • If considered to have sizable market power under Israeli law, the company could be subject to certain restrictions that may limit its ability to freely conduct business.
  • Failure to comply with Israeli law restrictions concerning employment of employees on rest days and religious holidays may expose the company to administrative and criminal liabilities.
  • Failure to manage inventory effectively could materially adversely affect results of operations.
  • Dependence on the senior management team and other skilled and experienced personnel; the loss of any of these individuals could materially and adversely affect the business.

Future Outlook

The company expects to rely on Production Business Partners (PBPs) for substantially all of its engineered stone products in 2026 and aims to increase purchases from PBPs. Significant future growth is anticipated from the U.S. market, requiring both organic expansion and strategic acquisitions to remain competitive. The company will continue to invest in strengthening market penetration and exploring alternative sales channels. Additional verdicts in silicosis cases are expected in the coming months, and the company is monitoring the ITC global safeguards investigation on quartz surface products, with key determinations expected by April and May 2026. New operating lease agreements are expected to commence in 2026, and the company is evaluating the impact of new accounting standards (ASU 2025-05 and ASU 2025-10).

Management Comments

  • "Strongly disagree with the jury's verdict [in the Los Angeles County silicosis case] which we believe is not supported by the facts of the case, including its failure to acknowledge the proactive measures we have taken over the years to warn and educate about safe fabrication practices."
  • "While we certainly support initiatives aimed at improving health and safety, some of these [evolving legislation and regulation] may have an adverse effect on our business and financial performance."
  • "Our mission is to be the leading choice for surfaces all around the world. We believe that a significant portion of our future growth will come from our U.S. market where we see the greatest growth opportunity."
  • "We believe that in order to remain competitive in the long term, we will need to grow our business both organically and through acquisitions."
  • "We are taking the necessary steps to ensure supply of alternative materials to its Australian customers in line with its high standards."

Industry Context

StockSavvy.ai notes that the global countertop industry generated approximately $151.6 billion in sales to end consumers in 2024, with engineered stone and porcelain being growing categories. Engineered quartz sales grew at a 14.3% CAGR from 1999-2024, and porcelain sales grew at a 30.5% CAGR from 2016-2024. Caesarstone's revenue decline of 10.4% in 2025 and 21.5% in 2024 indicates underperformance relative to these historical industry growth rates. The Australian ban on engineered stone containing crystalline silica, effective July 1, 2024, represents a significant regulatory shift impacting the engineered stone market, prompting the company's focus on crystalline silica-free (CSF) products and porcelain. The industry also faces intense competitive pressures from low-cost manufacturers and macroeconomic headwinds like high inflation and interest rates affecting home renovation and construction spending.

Comparison to Industry Standards

  • Caesarstone's revenue decreased by 10.4% in 2025, contrasting sharply with the global engineered quartz sales to end-consumers which grew at a 14.3% compound annual growth rate between 1999 and 2024, and the overall global countertop market's 5.2% CAGR during the same period, indicating significant underperformance.
  • The company's gross margin declined to 18.4% in 2025, which is a negative trend compared to its own 21.8% in 2024, and likely below industry leaders who maintain higher margins through efficiency or premium pricing.
  • The Australian ban on engineered stone containing crystalline silica, effective July 1, 2024, directly impacted Caesarstone's sales in Australia, which decreased by 10.5% in 2025. This regulatory action sets a precedent that could affect other markets, requiring the company to adapt faster than competitors who may have a more diversified product portfolio or less exposure to engineered stone.
  • Caesarstone's strategic shift to crystalline silica-free (CSF) products and increased reliance on Production Business Partners (PBPs) for manufacturing (73% in 2025, aiming for 100% in 2026) is a response to evolving industry health and safety standards and competitive pressures, but also introduces new operational risks compared to companies with established in-house alternative material production.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
President, Caesarstone USNAKobi BrennerOctober 2025Appointment to lead U.S. operations, previously served as CFO of Caesarstone US.
DirectorNAEran CohenNovember 2025Appointment to the board of directors.
DirectorNAYaron ArziDecember 2025Appointment to the board of directors.
Chief Information Officer and VP Global OperationsNAChen LivneMarch 2024Appointment to lead IT and global operations.
Vice President, Global Human ResourcesNALilach GilboaJuly 2023Re-appointment to the role, previously held the position from 2007-2018.
Global Chief Marketing OfficerHead of Product MarketingIdit Maayan ZoharJanuary 2026Returned to the role after serving as Head of Product Marketing during 2025.
DirectorNAMaxim OhanaOctober 2023Appointment to the board of directors, previously served as Chairman of the Board from 2010-2013.
Executive (unspecified)Jose Louis RamonNANANo longer serving the company as of the report date.
Executive (unspecified)Erik ChristensenNANANo longer serving the company as of the report date.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Exemption from Nasdaq RulesThe company relies on the foreign private issuer exemption with respect to the quorum requirement for shareholder meetings, allowing a 25% quorum instead of Nasdaq's 33 1/3% for board-convened meetings.OngoingPotentially provides less protection to shareholders compared to U.S. domestic issuers by lowering the threshold for shareholder meeting quorums.
SEC Reporting RequirementsDirectors and officers will become subject to Section 16(a) reporting provisions of the Exchange Act.March 18, 2026Increases transparency regarding insider transactions for directors and certain officers, aligning with U.S. domestic issuer standards for these individuals.
Exclusive Forum ProvisionsArticles of association designate U.S. federal district courts as the sole and exclusive forum for Securities Act claims and the competent courts of Tel Aviv, Israel, for disputes under the Companies Law or Israeli Securities Law.OngoingMay limit shareholders' ability to choose a judicial forum for disputes, potentially increasing costs and discouraging certain lawsuits against the company and its management.
Audit Committee CompositionThe audit committee consists of Ms. Nurit Benjamini (Chairperson), Ms. Lily Ayalon, and Mr. Yaron Arzi, all of whom are independent under Nasdaq rules and qualify as audit committee financial experts.OngoingEnsures strong financial oversight and compliance with SEC and Nasdaq requirements for audit committee independence and expertise.
Compensation PolicyThe compensation policy for executive officers and directors was last re-adopted in October 2023, requiring review and re-adoption at least once every three years.October 2023Provides a structured framework for executive and director compensation, subject to periodic review and shareholder approval, aiming to align incentives with company objectives.
Cybersecurity GovernanceThe board of directors delegates cybersecurity risk oversight to the Audit Committee, which receives reports from management and internal auditors. A Cybersecurity Steering Committee, including the CEO, CFO, and CIO, assesses and manages risks.OngoingEstablishes a formal structure for managing cybersecurity risks, enhancing protection of critical systems and information, and promoting compliance with relevant frameworks like NIST.

Legal Proceedings

  • As of December 31, 2025, the company is subject to 618 pending bodily injury claims globally (40 in Israel, 151 in Australia, 427 in the United States) alleging silicosis from exposure to respirable crystalline silica (RCS) related to its products.
  • A provision of $47.3 million was recorded as of December 31, 2025, for probable and estimable losses from these claims.
  • Insurance receivables for silicosis-related claims decreased to $11.0 million in 2025 from $32.1 million in 2024, with recovery from U.S. insurance carriers not considered probable due to ongoing legal disputes.
  • In August 2024, an adverse jury verdict in Los Angeles County, California, allocated 15% liability ($13.0 million) to Caesarstone; the company is appealing this verdict.
  • In May 2025, a complete defense verdict was received in a similar silicosis case in Los Angeles County, California, which plaintiffs are appealing.
  • The company settled one U.S. claim in February 2025 and four additional claims in February 2026.
  • 35 U.S. claims are considered 'reasonably possible' with a potential loss range of $0.5 million to $13 million per claim, while 387 U.S. claims are in early stages with potential loss not reasonably estimable.
  • A putative class action lawsuit was filed on January 14, 2026, in the Federal Court for the Northern District of California, seeking funding for medical monitoring of California workers allegedly exposed to artificial stone dust.
  • The company is involved in other legal proceedings and claims in the ordinary course of business related to environmental, contract, employment, product liability, and warranty matters, for which adequate reserves are believed to be recorded.

Related Party Transactions

  • Kibbutz Sdot-Yam and Tene Investment in Projects 2016, L.P. are controlling shareholders, beneficially holding 40.6% of the company's outstanding ordinary shares as of February 27, 2026.
  • The company has a Manpower Agreement with Kibbutz Sdot-Yam, under which the Kibbutz provides labor services. Payments to the Kibbutz for these services were $1.3 million in 2025, $1.3 million in 2024, and $1.6 million in 2023.
  • A Services Agreement with Kibbutz Sdot-Yam, amended in August 2024 for a three-year term, covers various operational services. Payments were $0.6 million in 2025, $0.7 million in 2024, and $0.8 million in 2023.
  • Land Use Agreements with Kibbutz Sdot-Yam for the company's headquarters, R&D facilities, and former Bar-Lev manufacturing facility. Annual fees paid were $8.1 million in 2025, $8.1 million in 2024, and $7.9 million in 2023.
  • The company subleased a majority of the available land at the Sdot-Yam facility to third parties, generating approximately $3.4 million in 2025 and $1.1 million in 2024.
  • A Management Services Agreement with Tene Growth Capital 3 Funds Management Company Ltd., amended in September 2024 for an additional 3 years, provides services of an Executive Chairman of the Board and business development advice for an aggregate annual management fee of NIS 750,000 plus VAT.

Stakeholder Impact

  • **Shareholders**: Face significant financial losses, declining revenue, increased legal liabilities, and potential share price volatility, including risks of delisting from Nasdaq. The substantial ownership by Kibbutz Sdot-Yam and Tene limits the influence of other shareholders.
  • **Employees**: Experienced a workforce reduction of 266 employees in 2025 due to plant closures. The company faces challenges in attracting and retaining skilled personnel in a competitive market.
  • **Customers**: The Australian ban on engineered stone and past quality issues with newly introduced products could impact customer satisfaction and demand. The company's focus on crystalline silica-free (CSF) products aims to address evolving customer needs and regulatory concerns.
  • **Suppliers/Production Business Partners (PBPs)**: Increased reliance on PBPs for manufacturing introduces potential risks related to intellectual property leakage, quality control, and supply chain disruptions, which could affect the stability of these partnerships.
  • **Creditors**: Increased legal liabilities and negative cash flow from operations could strain the company's liquidity, potentially impacting its ability to meet existing and foreseeable financial obligations, including its $2.4 million utilized credit line.
  • **Regulatory Authorities**: The company is under scrutiny for silicosis claims, environmental compliance at its facilities, and adherence to trade policies, leading to potential fines, investigations, and compliance costs.

Next Steps

  • Continue appealing the adverse silicosis verdict in Los Angeles County, California.
  • Monitor the appeal of the defense verdict in Los Angeles County, California.
  • Monitor the class action lawsuit in the Federal Court for the Northern District of California regarding medical monitoring for workers exposed to artificial stone dust.
  • Continue legal disputes with insurance carriers regarding coverage for silica-related claims.
  • Monitor the ITC global safeguards investigation on imports of quartz surface products (QSP) from all countries into the U.S., with a serious injury determination by April 2026 and recommendations to the President by May 2026.
  • Continue efforts to comply with new laws and regulations, such as the Australian ban on engineered stone containing crystalline silica, and adjust to resulting market dynamics.
  • Continue R&D efforts on innovative crystalline silica-free (CSF) products and porcelain products for various global markets.
  • Expand the network of Production Business Partners (PBPs) and increase the number of products that can be manufactured at multiple facilities.
  • Optimize the distribution network in the United States, including expansion into the South, Southeast, and Ohio Valley markets.
  • Evaluate other potential markets for direct distribution.
  • Implement requirements of Amendment 13 to Israel's Privacy Protection Law.
  • Re-evaluate qualification as a foreign private issuer on June 30, 2026.
  • Directors and officers will become subject to Section 16(a) reporting provisions effective March 18, 2026.
  • Seek subsequent extensions for business licenses on an ongoing basis.
  • Cooperate with Bryan County, GA, and Georgia Environmental Protection Division inquiries into alleged contamination at the closed Richmond Hill facility.
  • Update the business license for Israeli sites according to current activities, pending Fire Department approval.
  • Evaluate the impact of ASU 2025-05 (Financial Instruments Credit Losses) and ASU 2025-10 (Government Grants) on consolidated financial statements.

Key Dates

DateDescription
2023-10-30Shareholders approved the CEO's employment agreement and director equity compensation.
2023-12-01Nurit Benjamini and Lily Ayalon re-elected to serve as external directors for another three-year term.
2023-12-31Fiscal year end for 2023 financial metrics.
2024-01-01Richmond Hill manufacturing facility ceased operations.
2024-07-01Australian ban on the use, supply, and manufacture of engineered stone slabs containing crystalline silica came into effect in most states and territories.
2024-08-07Adverse verdict received in Los Angeles County, California, jury allocated 15% liability ($13.0 million) to Caesarstone in a silicosis case.
2024-08-01Audit committee and board approved the amendment of the services agreement with Kibbutz Sdot-Yam for a three-year term.
2024-09-19Shareholders approved an amended management services agreement with Tene for an additional 3 years.
2024-10-01Kobi Brenner assumed the role of President of Caesarstone US.
2024-11-12Caesarstone's website was recognized by Forbes Advisor as one of the Top WordPress Websites.
2024-11-06The closing bid price of ordinary shares alternately fell below $1.00 per share, reaching a low of $0.86 on November 21, 2025.
2024-12-19California's occupational safety and health standards board approved emergency temporary standards applicable to the engineered stone fabrication process.
2024-12-31Fiscal year end for 2024 financial metrics.
2025-01-01Additional 2% excess tax imposed on Capital-Sourced Income in Israel became effective.
2025-02-01Settlement reached for an additional silicosis claim in the U.S.
2025-03-01Freedonia Custom Research report on global residential and commercial countertops dated.
2025-03-01Eran Cohen served as Chairman of Kibbutz Sdot Yam's Economic Council.
2025-05-29Complete defense verdict received in a similar silicosis case in Los Angeles County, California, which plaintiffs are appealing.
2025-06-01SEC issued a concept release soliciting public comment on potential changes to the definition of a foreign private issuer.
2025-07-01Company and certain U.S. insurance carriers initiated proceedings for declaratory relief to determine proper interpretation and application of U.S. product liability insurance policies.
2025-10-01Company exercised the remaining portion of its call option and acquired the remaining interest in Lioli for approximately $1.9 million, achieving 100% ownership.
2025-11-01Eran Cohen appointed as a director.
2025-11-01ITC instituted a global safeguards investigation under Section 201 of the Trade Act of 1974 on imports of QSPs from all countries into the U.S.
2025-12-01Yaron Arzi appointed as a director.
2025-12-31Fiscal year end for 2025 financial metrics, Bar Lev manufacturing facility closed.
2026-01-01ASU 2025-05 (Financial Instruments Credit Losses) becomes effective for the company.
2026-01-01Idit Maayan Zohar returned to the role of Global Chief Marketing Officer.
2026-01-14Class action lawsuit filed against the company and other manufacturers in Federal Court for the Northern District of California seeking medical monitoring for workers exposed to artificial stone dust.
2026-02-01Settlement reached with respect to four additional silicosis claims.
2026-02-09Consent of Freedonia Custom Research, Inc. dated.
2026-02-20U.S. Supreme Court held that tariffs imposed under IEEPA exceeded authority, and a subsequent executive order terminated their collection.
2026-02-27Date of beneficial ownership information for directors, executive officers, and major shareholders.
2026-03-04Date of CEO and CFO certifications for the annual report.
2026-03-18Directors and officers will become subject to Section 16(a) reporting provisions of the Exchange Act.
2026-04-01ITC scheduled to make its serious injury determination for the global safeguards investigation on QSPs.
2026-05-01ITC scheduled to submit its report and recommendations to the President for the global safeguards investigation on QSPs.
2026-06-30Company will re-evaluate its qualification as a foreign private issuer.
2029-01-01ASU 2025-10 (Government Grants) becomes effective for the company.

Recommendation

strong sell

The company's financial performance is in severe decline, marked by a substantial net loss of $137.5 million and negative adjusted EBITDA. Revenues continue to fall significantly, and gross margins are eroding. The escalating legal liabilities from silicosis claims, coupled with uncertain insurance coverage, present a major and unquantifiable financial risk. Operational restructuring, including plant closures, has resulted in large impairment charges, indicating fundamental business challenges. Macroeconomic headwinds and intense competition further exacerbate the negative outlook. The stock price has already experienced significant volatility and faces potential delisting from Nasdaq. These factors collectively point to a highly distressed company with substantial downside risk, making a 'strong sell' recommendation appropriate for a seasoned investor or institution.

Keywords

Engineered stone, Quartz surfaces, Porcelain slabs, Countertops, Silicosis claims, Product liability, Manufacturing restructuring, Plant closures, Impairment charges, Net loss, EBITDA loss, Revenue decline, Supply chain, Production Business Partners, Australia ban, Israel, United States, Canada, Lioli acquisition, Nasdaq listing, Corporate governance, Related party transactions, SEC filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.